These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2154921)

  • 21. Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
    Thigpen T; Blessing JA; Yordan E; Valea F; Vaccarello L
    Gynecol Oncol; 1996 Oct; 63(1):120-2. PubMed ID: 8898180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
    Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
    Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study.
    Muss HB; Bundy BN; Christopherson WA
    Am J Clin Oncol; 1989 Apr; 12(2):142-4. PubMed ID: 2705404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Look K; Anderson B
    Invest New Drugs; 1991 May; 9(2):207-8. PubMed ID: 1874603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Currie J; Blessing JA; Muss HB; Fowler J; Berman M; Burke TW
    Gynecol Oncol; 1996 Apr; 61(1):27-30. PubMed ID: 8626112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature.
    Kanjeekal S; Chambers A; Fung MF; Verma S
    Gynecol Oncol; 2005 May; 97(2):624-37. PubMed ID: 15863170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
    Yoo HJ; Lim MC; Lim S; Park JY; Kang S; Park SY; Seo SS
    Arch Gynecol Obstet; 2012 Dec; 286(6):1529-35. PubMed ID: 22825691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.
    Hyman DM; Sill MW; Lankes HA; Piekarz R; Shahin MS; Ridgway MR; Backes F; Tenney ME; Mathews CA; Hoffman JS; Aghajanian C; Hensley ML
    Gynecol Oncol; 2017 Jan; 144(1):96-100. PubMed ID: 28094040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of metastatic uterine leiomyosarcoma with cisplatin, pirarubicin, and ifosfamide.
    Hirota Y; Miyamura K; Hayata T; Miyakawa I
    Gynecol Obstet Invest; 1997; 44(1):70-2. PubMed ID: 9251960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Blessing JA; Malfetano JH
    Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Orr JW; DiSaia PJ
    Cancer Treat Rep; 1986 Feb; 70(2):271-4. PubMed ID: 3948191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
    Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
    J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
    Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
    Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Edmonson JH; Blessing JA; Cosin JA; Miller DS; Cohn DE; Rotmensch J
    Gynecol Oncol; 2002 Jun; 85(3):507-10. PubMed ID: 12051882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide.
    Hannigan EV; Freedman RS; Elder KW; Rutledge FN
    Gynecol Oncol; 1983 Apr; 15(2):224-9. PubMed ID: 6687580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of advanced uterine sarcoma with adriamycin.
    Hannigan EV; Freedman RS; Elder KW; Rutledge FN
    Gynecol Oncol; 1983 Aug; 16(1):101-4. PubMed ID: 6884822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hatch KD; Soper JT; Webster KD; Kemp GM
    Am J Clin Oncol; 1990 Feb; 13(1):61-3. PubMed ID: 2407104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: a gynecologic oncology group study.
    Fowler JM; Blessing JA; Burger RA; Malfetano JH
    Gynecol Oncol; 2002 May; 85(2):311-4. PubMed ID: 11972393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Long HJ; Blessing JA; Sorosky J
    Gynecol Oncol; 2005 Nov; 99(2):339-42. PubMed ID: 16051328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.